Yahoo Web Search

Sign In

Search results

  1. en.wikipedia.org › wiki › Shire_(pharmaceutical_company)Shire (pharmaceutical company) - Wikipedia

    Shire plc was a UK-founded Jersey-registered specialty biopharmaceutical company. Originating in the United Kingdom with an operational base in the United States, its brands and products included Vyvanse, Lialda, and Adderall XR. Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019.

  2. www.takeda.com › newsroom › newsreleasesTakeda Completes Acquisition of Shire, Becoming a Global,...

    Jan 8, 2019 · OSAKA, JAPAN, January 8, 2019 – Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its acquisition of Shire plc (“Shire”), becoming a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan.

    • 2-ch?me-1-1 Nihonbashihonch?, Chuo City, 103-0023, Tokyo

  3. www.pharmavoice.com › news › takeda-shire-chris-arendt-nimbusFive years after closing the Shire deal, Takeda is ready to...

    Jan 19, 2024 · Five years ago this month, Takeda Pharmaceuticals completed a $62 billion acquisition of Shire — one of the largest deals in pharma history. The anniversary has triggered a fresh wave of scrutiny over its value and mixed bag of results.

    • Meagan Parrish

  4. www.takeda.com › proposed-acquisition-of-shire-plc-by-takedaProposed Acquisition of Shire plc by Takeda

    May 8, 2018 · Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and Shire plc (LON: SHP) (“Shire”) today announced that they have reached agreement on the terms of a recommended offer pursuant to which Takeda will acquire the entire issued and to be issued ordinary share capital of Shire.

    • 2-ch?me-1-1 Nihonbashihonch?, Chuo City, 103-0023, Tokyo

  5. www.reuters.com › article › businessJapan's Takeda clinches $62 billion Shire deal as pharma M&A...

    May 8, 2018 · Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping the drugs industry.

  6. www.takeda.com › newsroom › shire-news-releasesShire completes combination with Baxalta creating the global ......

    Shire now has more than 50 programs in clinical development, with a balanced mix of early, mid and late-stage projects. With over 22,000 employees across more than 100 countries, Shire’s expanded global reach and best-in-class products offer the potential to help even more patients around the world with significant unmet needs.

  7. www.biopharmadive.com › news › takeda-shire-takeover-62Takeda secures Shire takeover with $62B deal | BioPharma Dive

    May 8, 2018 · Takeda Pharmaceutical will pay $62 billion to acquire rare disease biotech Shire, securing on Tuesday a deal that will create one of the world's largest drugmakers by sales and transform the 237-year-old Japanese company.